Breaking News

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

Genius AI Detection Receives FDA Clearance – New Deep Learning-based Software Designed to Help Radiologists Detect Subtle Potential Cancers in Breast Tomosynthesis Images

This new technology, represents a pivotal milestone in the early detection of breast cancer, as studies showed Genius AI Detection software aids in the identification and early detection of breast cancer when used with the Genius® 3D Mammography™ exam.

Passio Pump Drainage System Granted 510(k) for Additional Indication for Home Use

The Passio Pump Drainage System consists of the Passio Catheter, a Handheld Control Unit (pump) and a Disposable Collection Kit, which includes a redressing kit, for drainage of recurrent and symptomatic pleural effusion.

Boston Scientific Signs Definitive Agreement to Divest BTG Specialty Pharmaceuticals Business

Boston Scientific notes SERB, backed by private equity firm Charterhouse Capital Partners since 2017, owns a diversified portfolio of prescription medicines focused on rare and life-threatening diseases.

RSIP Vision Launches a New Knee Segmentation and Landmark Detection from X-ray Module

September 15, 2020

RSIP Vision, a global supplier of medical artificial intelligence (AI), computer vision, and image processing technology, has announced the release of an innovative new AI bone segmentation and landmark detection module that will dramatically improve pre-operative planning, intraoperative guidance, and post-operative patient experience in knee replacement surgery.

By leveraging the power of RSIP Vision’s novel AI module, surgeons and radiologists can automatically collect – from regular X-ray images only – the accurate measurements they want. This provides them with the critical data they need to design the best possible implants for patients. This crucial planning process is now simplified, making it faster and more precise, allowing the surgeon to plan the implant positioning with perfect accuracy. This module will serve a much wider segment than the existing CT module since most medical centers use X-ray for these procedures on a daily basis.

Knee replacement surgery is one of the most common procedures in orthopedics, with more than 790,000 surgeries carried out each year in the US alone. According to the American Academy of Orthopaedic Surgeons (AAOS), this figure is expected to grow to 1.28m by 2030. It can be a difficult procedure with a painful recovery and a long rehabilitation period.

In total knee replacement surgery, also known as total knee arthroplasty (TKA), the severely damaged bone is replaced with an implant. Implants can be positioned in several ways, and accurately fitting this implant is crucial to the success of the operation and future health and quality of life outcomes for the patients.

X-ray images are commonly used to get a good understanding of the bone, including its size and location. Numerical measurements that define resection lines, implant size, and final bone position are vital to determine the optimal configuration of the implant location. This process relies heavily on the accurate detection of anatomical landmarks and segmentation of each bone, to provide important data such as angles and surface measurements.

However, X-ray images can be challenging for manual interpretation and measurements. In recent years, AI and deep learning introduced significant advances to the medical field; this enables RSIP Vision to develop the new module which accurately detects and maps the anatomical structure of the bones from X-ray only.

RSIP Vision founder and CEO, Ron Soferman, said: “This novel technology marks another milestone in RSIP Vision’s revolutionary work to improve the lives of millions of people who undergo knee surgery every year. Our expertise in deep learning, image analysis and computer vision, combined with years of experience in the medical domain, has enabled us to develop a line of AI modules tailored to the orthopedics field.

By reducing the planning and surgery time and solving the main challenges of orthopedic procedures, RSIP Vision’s innovative AI bone segmentation and landmark detection X-ray module provides a robust solution: it enhances the clinical capabilities of our clients, the large orthopedics vendors, allowing them to secure an improved patient outcome, a higher surgical success rate, and shorter recovery time.”

Latest Posts

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

1st Patients Enrolled in STEM Trial for `Treatment of Chronic Subdural Hematoma

This marks the first patients enrolled in a prospective, randomized, international trial of a liquid embolic agent for the treatment of chronic subdural hematoma (cSDH), a common disease affecting primarily older adults.

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

Don't Miss

New England Biolabs Announces Further Expansion of Their RNA Depletion Product Portfolio with the Launch of the NEBNext Custom RNA Depletion Design Tool and NEBNext RNA Depletion Core Reagent...

Together, these enable a fully customizable workflow for improved removal of specific RNAs, including abundant RNAs such as ribosomal RNA

INTERCEPT Blood System for Cryoprecipitation Receives FDA Approval States Cerus Corporation

The system is used to produce Pathogen Reduced Cryoprecipitated Fibrinogen Complex for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. 

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials.